UNITED THERAPEUTICS Corp — Director's Dealing 2021

Nov 5, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: UNITED THERAPEUTICS Corp (UTHR)
CIK: 0001082554
Period of Report: 2021-11-04

Reporting Person: ROTHBLATT MARTINE A (Director, Chairman & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-11-04	Common Stock	M	3083	$53.42	Acquired	3213	Direct
2021-11-04	Common Stock	S	3083	$200.00	Disposed	130	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-11-04	Common Stock (Derivative)	$53.42	M	3083	Disposed	2022-12-31	Common Stock (3083)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	166	Indirect
Common Stock	656529	Indirect

Footnotes

F1: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.